TGF-β signaling is one of the key pathways in tumor progression and a general suppression of TGF-βmediators by the pleiotropically acting miR-302/367 cluster may be one of the important reasons for its anti-tumoreffects in breast cancer cells. Here, TGFB1 is linked to breast carcinoma.